Learning Objectives
August 1-2, 2008
New York, NY
-
Describe the current status of state-of-the-art therapies of lung cancer, including chemotherapy and radiation therapy
-
Discuss the management of subhistologies of NSCLC
-
Define the current status of multimodality therapy in the treatment of localized and advanced lung cancer
-
Outline the clinical data supporting the use of EGFR inhibitors in the treatment of lung cancer
-
Review agents that target angiogenesis in lung cancer, including the safety profile and efficacy
-
Specify the impact of multi-targeted kinase inhibitors in the management of lung cancer
-
Describe novel therapeutic agents that potentially improve upon standard chemotherapeutics
-
Cite recent data on surgical advances in non?small-cell lung cancer
-
Define the importance of supportive care in the management of lung cancer






